No Data
GT Biopharma Initiated at Buy by Roth MKM
GT Biopharma Price Target Announced at $11.00/Share by Roth MKM
GT Biopharma Analyst Ratings
Roth MKM Initiates GT Biopharma(GTBP.US) With Buy Rating, Announces Target Price $11
Express News | GT Biopharma Inc - Receives Nasdaq Delisting Notice for Falling Below $2.5 Mln Equity Minimum
Express News | GT Biopharma Announces Partnership With University Of Minnesota For Phase 1 Clinical Trial Of GTB-3650 Tri-Specific Killer Engager For High-Risk MDS, Refractory/Relapsed AML, And Minimal Residual Disease; University To Sponsor IND Application
No Data
